These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2873909)

  • 1. The role of the sympathetic nervous system in 2-kidney DOCA-hypertensive Yucatan miniature swine.
    Zambraski EJ; Ciccone CD; Izzo JL
    Clin Exp Hypertens A; 1986; 8(3):411-24. PubMed ID: 2873909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phenoxybenzamine, metoprolol, captopril, and meclofenamate on cardiovascular function in deoxycorticosterone acetate hypertensive Yucatan miniature swine.
    Ciccone CD; Zambraski EJ
    Can J Physiol Pharmacol; 1983 Feb; 61(2):149-53. PubMed ID: 6340808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Sato Y; Ando K; Fujita T
    Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic responses to DOCA in young pigs.
    Miller AW; Bohr DF; Schork AM; Terris JM
    Hypertension; 1979; 1(6):591-7. PubMed ID: 541051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal function in chronically sympathectomized deoxycorticosterone acetate-treated miniature swine.
    Thomas GD; Zambraski EJ
    Proc Soc Exp Biol Med; 1991 Jul; 197(3):331-6. PubMed ID: 1906181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension.
    O'Hagan KP; Thomas GD; Zambraski EJ
    Am J Hypertens; 1990 Jan; 3(1):62-4. PubMed ID: 2302330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prostaglandin inhibition on renal function in deoxycorticosterone-acetate hypertensive Yucatan miniature swine.
    Ciccone CD; Zambraski EJ
    Prostaglandins Med; 1981 Nov; 7(5):395-402. PubMed ID: 7323208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats.
    Rascher W; Schömig A; Dietz R; Weber J; Gross F
    Eur J Pharmacol; 1981 Nov; 75(4):255-63. PubMed ID: 7318911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension.
    Kohlmann O; Ginoza M; Cezaretti ML; Zanella MT; Ribeiro AB; Tavares A; Ramos OL; Leeman SE; Gavras I; Gavras H
    Hypertension; 1995 Dec; 26(6 Pt 2):1186-9. PubMed ID: 7498993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of inhibiting brain reactive oxygen species on sympathetic nerve activity in DOCA-salt hypertensive rats].
    Zhang Q; Tan Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1632-6. PubMed ID: 25413063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical function in deoxycorticosterone acetate (DOCA)-hypertensive Yucatan miniature swine.
    Carsia RV; Weber H; Haight KK; Cimini CM; Zambraski EJ
    Proc Soc Exp Biol Med; 1985 Apr; 178(4):591-8. PubMed ID: 2984691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic characteristics of conscious deoxycorticosterone acetate hypertensive rats.
    Shimamoto H; Iriuchijima J
    Jpn J Physiol; 1987; 37(2):243-54. PubMed ID: 2957535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs.
    Hamed AT; Lokhandwala MF
    Clin Exp Hypertens A; 1982; 4(6):867-81. PubMed ID: 6284412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice.
    Obst M; Gross V; Luft FC
    J Hypertens; 2004 Oct; 22(10):1889-94. PubMed ID: 15361759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoregulatory capacity in renal and mesenteric vasculatures of mineralocorticoid hypertensive dogs.
    Stoos BA; Metting PJ; Britton SL
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1205-13. PubMed ID: 1681741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aortic constriction and renal denervation in DOCA-hypertensive swine.
    Zambraski EJ; Ciccone CD
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1223-31. PubMed ID: 3322043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.